申请人:XW LABORATORIES INC.
公开号:US20200102289A1
公开(公告)日:2020-04-02
The present invention relates compounds of Formula (A) as H3R antagonists, as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of Histamine 3 Receptor (H3R) functions. The present invention also relates to the uses of the compounds or pharmaceutical compositions in treating or preventing certain disorders and diseases which relate to H3R functions in humans.
本发明涉及作为H3R拮抗剂的化合物(A)的公式,以及它们的制备和用途,并进一步涉及包含这些化合物的药物组合物及其用途作为组胺3受体(H3R)功能调节剂。本发明还涉及这些化合物或药物组合物在治疗或预防与人类H3R功能相关的某些疾病和疾病中的用途。